pulmonary surfactant surfaceactive complex phospholipids proteins formed type ii alveolar proteins lipids make surfactant hydrophilic hydrophobic regions adsorbing airwater interface alveoli hydrophilic head groups water hydrophobic tails facing towards air main lipid component surfactant dipalmitoylphosphatidylcholine dppc reduces surface tension medication pulmonary surfactant model list essential medicines important medications needed basic health alveoli compared gas water alveoli wet surround central air space surface tension acts airwater interface tends make bubble smaller decreasing surface area interface gas pressure p needed keep equilibrium collapsing force surface tension γ expanding force gas alveolus radius r expressed equation compliance ability lungs thorax expand lung compliance defined volume change per unit pressure change across lung measurements lung volume obtained controlled inflationdeflation normal lung show volumes obtained deflation exceed inflation given pressure difference inflation deflation volumes given pressure called hysteresis due airwater surface tension occurs beginning inflation however surfactant decreases alveolar surface tension seen cases premature infants infant respiratory distress syndrome normal surface tension water dyncm mnm lungs dyncm mnm however end expiration compressed surfactant phospholipid molecules decrease surface tension low nearzero levels pulmonary surfactant thus greatly reduces surface tension increasing compliance allowing lung inflate much easily thereby reducing work breathing reduces pressure difference needed allow lung inflate lungs compliance ventilation decrease lung tissue becomes diseased alveoli increase size surfactant becomes spread surface liquid increases surface tension effectively slowing rate expansion alveoli also helps alveoli lungs expand rate one expands quickly experience large rise surface tension slowing rate expansion also means rate shrinking regular one reduces size quickly surface tension reduce alveoli contract easily surfactant reduces surface tension readily alveoli smaller surfactant concentrated surface tension draws fluid capillaries alveolar spaces surfactant reduces fluid accumulation keeps airways dry reducing surface surfactant immune function primarily attributed two proteins spa spd proteins bind sugars surface pathogens thereby opsonize uptake phagocytes also regulates inflammatory responses interacts adaptive immune response surfactant degradation inactivation may contribute enhanced susceptibility lung inflammation dipalmitoylphosphatidylcholine dppc phospholipid two saturated chains phosphate group quaternary amine group attached dppc strongest surfactant molecule pulmonary surfactant mixture also higher compaction capacity phospholipids apolar tail less bent nevertheless without substances pulmonary surfactant mixture dppcs adsorption kinetics slow happens primarily phase transition temperature gel liquid crystal pure dppc higher human bodys temperature phosphatidylcholine molecules form lipid surfactant saturated acyl chains phosphatidylglycerol pg forms lipids surfactant unsaturated fatty acid chains fluidize lipid monolayer interface neutral lipids cholesterol also present components lipids diffuse blood type ii alveolar cells assembled packaged secretion secretory organelles called lamellar bodiescitation needed proteins make remaining surfactant half plasma proteins rest formed apolipoproteins surfactant proteins spa spb spc spd apolipoproteins produced secretory pathway type ii cells undergo much posttranslational modification ending lamellar bodies concentric rings lipid protein µm diameter sp proteins reduce critical temperature dppcs phase transition value lower improves adsorption interface spreading compression interface causes phase change surfactant molecules liquidgel even gelsolid fast adsorption velocity necessary maintain integrity gas exchange region lungs sp protein distinct functions act synergistically keep interface rich dppc lungs expansion contraction changes surfactant mixture composition alter pressure temperature conditions phase changes phospholipids crystal shape liquid phase freely spread surface form monolayer nevertheless observed lung region abruptly expanded floating crystals crack like icebergs sp proteins selectively attract dppc interface phospholipids cholesterol whose surfactant properties worse dppcs sp also fastens dppc interface prevent dppc squeezed surface area decreases also reduces interface number types pulmonary surfactants available exsitu measurements surface tension interfacial rheology help understand functionality pulmonary synthetic pulmonary surfactants animal derived surfactants even though surface tension greatly reduced pulmonary surfactant effect depend surfactants concentration interface interface concentration saturation limit depends temperature mixture composition ventilation variation lung surface area surfactants interface concentration usually level saturation surface increases inspiration consequently opens space new surfactant molecules recruited interface meanwhile expiration surface area decreases rate always excess rate surfactant molecules driven interface water film thus surfactant density air water interface remains high relatively preserved throughout expiration decreasing surface tension even also explains compliance greater expiration inspirationcitation needed sp molecules contribute increasing surfactant interface adsorption kinetics concentration saturation level also make weak bonds surfactant molecules interface hold longer interface compressed therefore ventilation surface tension usually lower equilibrium therefore surface tension varies according volume air lungs protects atelectasis low volumes tissue damage high volume surfactant production humans begins type ii cells alveolar sac stage lung development lamellar bodies appear cytoplasm weeks lamellar bodies secreted exocytosis alveolar lining fluid surfactant forms meshwork tubular full term infants estimated alveolar storage pool approximately mgkg surfactant preterm infants estimated mgkg club cells also produce component lung alveolar surfactant halflife hours secreted broken macrophages andor reabsorbed lamellar structures type ii pneumocytes surfactant dppc dipalmitoylphosphatidylcholine recycled alveolar space back type ii pneumocyte process believed occur spa stimulating receptormediated clathrin dependent taken alveolar macrophages digested late von identified function pulmonary surfactant increasing compliance lungs reducing surface tension however significance discovery understood scientific medical community time also realized importance low surface tension lungs newborn infants later middle pattle clements rediscovered importance surfactant low surface tension lungs end decade discovered lack surfactant caused infant respiratory distress syndrome httpsenwikipediaorgwikipulmonarysurfactant